Completed PHASE1 INTERVENTIONAL 4-arm NCT03269071

Neural Stem Cell Transplantation in Multiple Sclerosis Patients (STEMS)

Neural Stem Cell Transplantation in Multiple Sclerosis Patient: a Phase I Study

Sponsor: Fondazione Italiana Sclerosi Multipla

Conditions Progressive Multiple Sclerosis

Interventions human fetal-derived Neural Stem Cells (hNSCs)

Updated 7 times since 2017 Last updated: Sep 2, 2021 Started: May 17, 2017 Primary completion: Jul 31, 2021 Completion: Jul 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Progressive Multiple Sclerosis, this trial is completed. The trial is conducted by Fondazione Italiana Sclerosi Multipla and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Oct 2021 — Jul 2024 [monthly]

Completed PHASE1

Status: Enrolling By Invitation → Completed
Jan 2021 — Oct 2021 [monthly]

Enrolling By Invitation PHASE1
Mar 2019 — Jan 2021 [monthly]

Enrolling By Invitation PHASE1

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Enrolling By Invitation PHASE1
Sep 2017 — Jun 2018 [monthly]

Enrolling By Invitation PHASE1

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Italiana Sclerosi Multipla
IRCCS San Raffaele

Data source: IRCCS San Raffaele

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy